Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 13, 2004
- PFSB to Request \10.26 Bil. with 1.7% Increase for FY2005 Budget
September 13, 2004
- Lifestyle Diseases No Longer Tending to Increase: JHA Survey
September 13, 2004
- GPs' Participation Needed for Recovery of Domestic Clinical Trials: OMA Seminar
September 13, 2004
- WORLD NEWS IN BRIEF
September 13, 2004
- Details Proposed for Advanced Services in Special Structural Reform Zone: Korosho
September 13, 2004
- MEDICAL DEVICE NEWS IN BRIEF
September 13, 2004
- REGULATORY NEWS IN BRIEF
September 13, 2004
- Semi-annual Business Results
September 13, 2004
- Importance of New Safety Measures Stressed: Mr Asonuma of PFSB
September 13, 2004
- DIAGNOSTIC NEWS IN BRIEF
September 13, 2004
- Precautions against Interstitial Pneumonia Required for 220 Active Ingredients: PFSB
September 13, 2004
- OTC NEWS IN BRIEF
September 13, 2004
- Korosho to Further Promote Mutual GMP Recognition of Drugs
September 13, 2004
- Korosho to Steadily Implement Its Industry Visions: Mr Futagawa
September 6, 2004
- WORLD NEWS IN BRIEF
September 6, 2004
- Korosho to Work to Increase Speed, Reliability of NDA Review: Mr Kawahara
September 6, 2004
- Problems Remain with Large Hospitals, Chain Pharmacies: FJPWA Survey
September 6, 2004
- CDFS's Committee on Blood Programs Discusses Its Own Management Policy
September 6, 2004
- MONITOR
September 6, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…